Cargando…
Therapeutic Potential for Intractable Asthma by Targeting L-Type Amino Acid Transporter 1
Bronchial asthma is a chronic disease characterized by airway inflammation, obstruction, and hyperresponsiveness. CD4(+) T cells, particularly T helper (Th) 2 cells, and their specific cytokines are important mediators in asthma pathogenesis. However, it has been established that Th subsets, other t...
Autores principales: | Hayashi, Keitaro, Kaminuma, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029068/ https://www.ncbi.nlm.nih.gov/pubmed/35454142 http://dx.doi.org/10.3390/biom12040553 |
Ejemplares similares
-
Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment
por: Hayashi, Keitaro, et al.
Publicado: (2017) -
L-type amino acid transporter 1 inhibitor suppresses murine Th2 cell-mediated bronchial hyperresponsiveness independently of eosinophil accumulation
por: Ito, Daiki, et al.
Publicado: (2021) -
Amino Acid Transporters as Potential Therapeutic Targets in Thyroid Cancer
por: Enomoto, Keisuke, et al.
Publicado: (2020) -
The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
por: Häfliger, Pascal, et al.
Publicado: (2019) -
L-Type amino acid transporter 1 as a target for drug delivery
por: Puris, Elena, et al.
Publicado: (2020)